Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

Eric Horvitz

Artificial_Intelligence

Latest Artificial Intelligence and Digital Health News - Sept 23rd to Oct 6th 2025

Watch Our Video Summary Capturing Top AI in Healthcare and Digital Health News…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Conference Previews
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: WellBeam $10M Series A
Public Health Video Recap—November 21, 2025
Public Health Today—21 November, 2025
Respiratory Today—November 21, 2025
Vaccines Today—November 21, 2025

Tags

ABO-503 Anavex Life Sciences Association of Migraine Disorders BBB shuttle biomarin pharmaceutical chronic obstructive pulmonary disease companion diagnostics CVD discovery alliances EJPC Elixir Medical ENDO 2025 endoluminal robotics equity Er-Kim Eric Horvitz Evaxion A/S federated learning Fenebrutinib GEP-NETs Growth hormone deficiency HDR Hippo pathway Hyperthyroidism IL-6 JASCAYD lurbinectedin march biosciences neurological epidemiology neuromuscular disease obesity therapeutics Opus Genetics PAD PANTHERx Rare pericarditis Phase 2 refractory angina respiratory clinical trials Rocket Pharmaceuticals SeCys-tRNA sk biopharm Taysha Gene Therapies Theranica warrants Women’s Health Fund

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: WellBeam $10M Series A
Public Health Video Recap—November 21, 2025
Public Health Today—21 November, 2025
Respiratory Today—November 21, 2025
Vaccines Today—November 21, 2025

TAGS

ABO-503 Anavex Life Sciences Association of Migraine Disorders BBB shuttle biomarin pharmaceutical chronic obstructive pulmonary disease companion diagnostics CVD discovery alliances EJPC Elixir Medical ENDO 2025 endoluminal robotics equity Er-Kim Eric Horvitz Evaxion A/S federated learning Fenebrutinib GEP-NETs Growth hormone deficiency HDR Hippo pathway Hyperthyroidism IL-6 JASCAYD lurbinectedin march biosciences neurological epidemiology neuromuscular disease obesity therapeutics Opus Genetics PAD PANTHERx Rare pericarditis Phase 2 refractory angina respiratory clinical trials Rocket Pharmaceuticals SeCys-tRNA sk biopharm Taysha Gene Therapies Theranica warrants Women’s Health Fund

Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy